Latest News
EU signs deal with GSK for supply of 220,000 treatments of its COVID-19 drug
28 July 2021 - The European Union has signed a contract with British pharmaceutical company GlaxoSmithKline Plc (LON:GSK) for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against COVID-19, Reute...
Kintor Pharmaceutical doses first Chinese patients in phase one GT20029 clinical trial
28 July 2021 - Kintor Pharmaceutical Limited (HKEX: 9939), a China-based clinical-stage biotechnology company, announced on Wednesday that it has dosed the first batch of subjects in its phase one clinical trial of GT20029 in China.The phase I trial,...
NRx Pharmaceuticals' intravenous ZYESAMI (aviptadil) receives Georgian Emergency Use Authorisation
28 July 2021 - NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage, global biopharmaceutical company, announced on Tuesday that it has received an Emergency Use Authorisation from the Nation of Georgia's prime minister and minister of hea...
Kineta successfully completes FDA pre-IND meeting for KVA12.1
28 July 2021 - Kineta Inc, a clinical stage biotechnology company, announced on Tuesday that it has successfully completed a pre-IND (Investigational New Drug) meeting with the US Food and Drug Administration (FDA) for the manufacturing, preclinical ...
Pulmatrix names new director
28 July 2021 - Pulmatrix Inc (NASDAQ: PULM), a clinical-stage biopharmaceutical company, announced on Tuesday that it has appointed Anand Varadan as its new director, effective 26 July 2021.Presently, Vardan serves as executive vice president, chief ...